Logo image of STTK

SHATTUCK LABS INC (STTK) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:STTK - US82024L1035 - Common Stock

2.01 USD
-0.05 (-2.43%)
Last: 11/25/2025, 8:14:02 PM
2.19 USD
+0.18 (+8.96%)
After Hours: 11/25/2025, 8:14:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to STTK. STTK was compared to 533 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for STTK as it has an excellent financial health rating, but there are worries on the profitability. STTK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year STTK has reported negative net income.
In the past year STTK has reported a negative cash flow from operations.
STTK had negative earnings in each of the past 5 years.
STTK had a negative operating cash flow in each of the past 5 years.
STTK Yearly Net Income VS EBIT VS OCF VS FCFSTTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

The Return On Assets of STTK (-96.88%) is worse than 73.92% of its industry peers.
The Return On Equity of STTK (-108.77%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -96.87%
ROE -108.77%
ROIC N/A
ROA(3y)-62.15%
ROA(5y)-42.4%
ROE(3y)-70.54%
ROE(5y)-47.99%
ROIC(3y)N/A
ROIC(5y)N/A
STTK Yearly ROA, ROE, ROICSTTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for STTK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STTK Yearly Profit, Operating, Gross MarginsSTTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

7

2. Health

2.1 Basic Checks

STTK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, STTK has more shares outstanding
STTK has more shares outstanding than it did 5 years ago.
There is no outstanding debt for STTK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
STTK Yearly Shares OutstandingSTTK Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
STTK Yearly Total Debt VS Total AssetsSTTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

STTK has an Altman-Z score of -0.92. This is a bad value and indicates that STTK is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.92, STTK perfoms like the industry average, outperforming 57.60% of the companies in the same industry.
There is no outstanding debt for STTK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.92
ROIC/WACCN/A
WACC8.68%
STTK Yearly LT Debt VS Equity VS FCFSTTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

STTK has a Current Ratio of 10.30. This indicates that STTK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 10.30, STTK belongs to the top of the industry, outperforming 82.18% of the companies in the same industry.
A Quick Ratio of 10.30 indicates that STTK has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 10.30, STTK belongs to the top of the industry, outperforming 82.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.3
Quick Ratio 10.3
STTK Yearly Current Assets VS Current LiabilitesSTTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

STTK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.33%, which is quite impressive.
Looking at the last year, STTK shows a very strong growth in Revenue. The Revenue has grown by 245.26%.
The Revenue for STTK have been decreasing by -10.37% on average. This is quite bad
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.58%
Revenue 1Y (TTM)245.26%
Revenue growth 3Y-42.45%
Revenue growth 5Y-10.37%
Sales Q2Q%-66.63%

3.2 Future

STTK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.18% yearly.
Based on estimates for the next years, STTK will show a very negative growth in Revenue. The Revenue will decrease by -14.87% on average per year.
EPS Next Y46%
EPS Next 2Y27.5%
EPS Next 3Y15.91%
EPS Next 5Y9.18%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
STTK Yearly Revenue VS EstimatesSTTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2031 100M 200M 300M 400M
STTK Yearly EPS VS EstimatesSTTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for STTK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STTK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STTK Price Earnings VS Forward Price EarningsSTTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STTK Per share dataSTTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as STTK's earnings are expected to grow with 15.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.5%
EPS Next 3Y15.91%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for STTK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SHATTUCK LABS INC

NASDAQ:STTK (11/25/2025, 8:14:02 PM)

After market: 2.19 +0.18 (+8.96%)

2.01

-0.05 (-2.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-25 2026-03-25/amc
Inst Owners55.29%
Inst Owner Change27.01%
Ins Owners2.24%
Ins Owner Change0.02%
Market Cap127.19M
Revenue(TTM)5.72M
Net Income(TTM)-62.00M
Analysts80
Price Target3.06 (52.24%)
Short Float %2.64%
Short Ratio2.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.92%
Min EPS beat(2)3.96%
Max EPS beat(2)5.88%
EPS beat(4)3
Avg EPS beat(4)4.66%
Min EPS beat(4)-13.57%
Max EPS beat(4)22.37%
EPS beat(8)6
Avg EPS beat(8)5.55%
EPS beat(12)10
Avg EPS beat(12)7.91%
EPS beat(16)12
Avg EPS beat(16)14.03%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)30.06%
PT rev (3m)21.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)40.05%
EPS NY rev (1m)0%
EPS NY rev (3m)22.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 42.44
P/FCF N/A
P/OCF N/A
P/B 2.25
P/tB 2.25
EV/EBITDA N/A
EPS(TTM)-1.02
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.88
OCFYN/A
SpS0.05
BVpS0.9
TBVpS0.9
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -96.87%
ROE -108.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-62.15%
ROA(5y)-42.4%
ROE(3y)-70.54%
ROE(5y)-47.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.06%
Cap/Sales 1.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.3
Quick Ratio 10.3
Altman-Z -0.92
F-Score6
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)129.96%
Cap/Depr(5y)216.45%
Cap/Sales(3y)603.98%
Cap/Sales(5y)369.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.58%
EPS Next Y46%
EPS Next 2Y27.5%
EPS Next 3Y15.91%
EPS Next 5Y9.18%
Revenue 1Y (TTM)245.26%
Revenue growth 3Y-42.45%
Revenue growth 5Y-10.37%
Sales Q2Q%-66.63%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
EBIT growth 1Y28.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year22.5%
EBIT Next 3Y2.44%
EBIT Next 5Y-5.63%
FCF growth 1Y43.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.26%
OCF growth 3YN/A
OCF growth 5YN/A

SHATTUCK LABS INC / STTK FAQ

What is the fundamental rating for STTK stock?

ChartMill assigns a fundamental rating of 2 / 10 to STTK.


What is the valuation status for STTK stock?

ChartMill assigns a valuation rating of 0 / 10 to SHATTUCK LABS INC (STTK). This can be considered as Overvalued.


Can you provide the profitability details for SHATTUCK LABS INC?

SHATTUCK LABS INC (STTK) has a profitability rating of 0 / 10.


What is the financial health of SHATTUCK LABS INC (STTK) stock?

The financial health rating of SHATTUCK LABS INC (STTK) is 7 / 10.